drugset / Trial / NCT04941781
PET Study to Determine the Relationship Between Plasma Concentrations and Muscarinic Type 1 Receptor (M1AChR) Occupancy of PIPE-307 in Healthy Volunteers
NaSingle-groupOpen-labelTreatment
Summary
This is a Phase 1, single-center, open-label, adaptive-design PET study to investigate the occupancy of brain muscarinic Type 1 receptors (M1AChR) by PIPE-307 in healthy volunteers.
Timeline
- Start
- 2021-09-01
- Primary completion
- 2021-11-10
- Completion
- 2021-11-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PIPE-307 | Unknown | — | Oral |